Modernatx, Inc.
Clinical trials sponsored by Modernatx, Inc., explained in plain language.
-
Major trial for first CMV vaccine halted Mid-Study
⭐️ VACCINE ⭐️ TerminatedThis study tested an experimental mRNA vaccine (mRNA-1647) to prevent cytomegalovirus (CMV) infection in healthy people aged 16 to 40. The trial enrolled over 7,400 participants, focusing on women who had never been infected with CMV. The study was terminated early, so final resu…
Phase: PHASE3 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:06 UTC
-
COVID vaccine trial for babies halted early – Here's what we know
⭐️ VACCINE ⭐️ TerminatedThis study looked at whether the mRNA-1273.214 COVID-19 vaccine is safe and works in infants as young as 12 weeks to under 6 months old. It was a small, early-stage trial that was stopped before completion. The main goal was to check for side effects like fever, fussiness, and in…
Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 10, 2026 13:24 UTC
-
MRNA therapy for rare acidemia shows promise but study halted early
Disease control TerminatedThis study tested an mRNA medicine called mRNA-3705 in 18 people with a rare genetic condition called methylmalonic acidemia, which causes harmful acid buildup in the body. The goal was to see if the treatment is safe and can lower acid levels. The study was stopped early, so res…
Phase: PHASE1, PHASE2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC